The article examines how different doses of psilocybin yield distinct behavioral changes and signs of neuroplasticity in mice, linking receptor engagement to both immediate effects and longer-term neural adaptations. It notes that moderate doses can reduce anxiety-like behavior while higher doses may produce antidepressant-like effects and increase markers of synaptic plasticity in the prefrontal cortex. The findings aim to inform more precise dosing approaches for potential psychedelic-inspired therapies.

This work interests psychology readers because it investigates how brain receptor activity translates into observable behavior and neural change, illustrating how dose-dependent pharmacology can influence emotional regulation and mood-related outcomes. It highlights the importance of mechanistic understanding in translating preclinical findings toward targeted interventions.

Article Title: Psilocybin produces different behavioral and brain-altering effects depending on the dose

Link to PsyPost Article: https://www dot psypost.org/psilocybin-produces-different-behavioral-and-brain-altering-effects-depending-on-the-dose/

Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.

#psycho pharmacology #psilocybin #neuroplasticity #5-HT2A #doseresponse

Generative modeling of single-cell gene expression for dose-dependent chemical perturbations. https://doi.org/10.1016/j.patter.2023.100817 #DeepLearning #VariationalAutoencoders #ChemicalPerturbation #DoseResponse #RiskAssessment

@eeyam @novid @PieterPeach Congratulations on the rediscovery of basic concepts of dose response relationships. As I wrote in my blog back in May 2020: https://chaasblog.wordpress.com/2020/05/18/its-the-dose-response-stupid/

#doseresponse #QMRA #riskassessment #SARSCoV2

It’s the Dose Response, Stupid

During the first campaign of Bill Clinton, James Carville hung a sign in the campaign office, “It’s the Economy, Stupid”.  Amidst the discussions on COVID19 and SARS-COV-2, the concept of dose-resp…

Charles Haas' Blog